Johnson & Johnson conducts research and development, manufactures, and sells products in the healthcare field. The company operates through three business segments – Consumer Health, Pharmaceutical, and Medical Devices.
The Consumer Health segment offers over-the-counter medicines, and products for personal healthcare used in the skin health/beauty, baby care, oral care, women’s health, and wound care markets. The Pharmaceutical segment focuses on six therapeutic areas – Immunology (rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis), Infectious Diseases (HIV/AIDS and Covid-19), Neuroscience (mood disorders, neurodegenerative disorders, and schizophrenia), Oncology (prostate cancer, hematologic malignancies, lung cancer, and bladder cancer), Cardiovascular and Metabolism (thrombosis, diabetes, and macular degeneration), and Pulmonary Hypertension (pulmonary arterial hypertension). The Medical Devices segment offers interventional solutions and products used in the orthopaedics, surgery, and vision fields.
The company’s portfolio of brands includes Tylenol, Zarbee’s, Neutrogena, Aveeno, Listerine, OGX, and Johnson’s. Johnson & Johnson offers innovative products that complement the use of traditional metal implants in trauma, spine, and craniomaxillofacial surgical procedures. Its biomaterials assist orthopaedic surgeons in repairing, protecting, and strengthening the structural core of the human body.
